The trajectory of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the healthcare arena . Despite its early success and creation of billions in earnings , the exclusivity end has opened the way for alternative medications, significantly diminishing income prospects . This shift raises questions abou